|
|
||||||||
Special Report |
1 Department of Clinical Chemistry, St. Elisabeth Hospital, PO Box 90151, 5000 LC Tilburg, The Netherlands. 2 Department of Pathology, University of Virginia Medical School, Charlottesville, VA. 3 Laboratoire de Biologie Polyvalente, Centre Hospitalier Général, Rodez, France. 4 Laboratory of Clinical Biochemistry, Haukeland University Hospital, and Division of General Practice, University of Bergen, Bergen, Norway. 5 Department of Clinical Chemistry, University of Szeged, Albert Szent-Gyorgyi Medical School, Szeged, Hungary.
aAuthor for correspondence. Fax 31-13-5352390; e-mail w.oosterhuis{at}elisabeth.nl.
Background: Guidelines are commonly used tools for supporting medical decisions. Formulating evidence-based recommendations has become a leading principle in guideline development.
Aim: This narrative review integrates the most recent methods of evidence-based guideline development and adapts those to the field of laboratory medicine.
Summary: We present a 10-step process and a list of criteria for the development of laboratory guidelines. Laboratory guidelines should be outcome oriented, be developed by a multidisciplinary team, and begin with a clear statement of the clinical question(s) that the use of the test(s) is addressing. The clinical questions define the type of study designs that offer the best evidence to answer those questions. Guidelines should be based on the critical appraisal and systematic review of literature and explicitly state the strength of evidence supporting each recommendation. Pragmatic considerations dictate that priority is given to topics with the highest clinical or economic impact. Scientific evidence is necessary but insufficient for recommendations, as considered judgment is required about benefits, harms, costs, and local applicability of recommendations. Formal consensus methods are needed when the evidence base is lacking or controversial. Guidelines should be disseminated widely and their impact monitored regularly. Regular reviewing is needed because the lack of timely updates is a major cause of nonadherence to guidelines.
Conclusions: Guidelines should be developed in a transparent process by a multidisciplinary team, with graded recommendations based on critically appraised scientific studies. Systematic, standardized, and explicit methodology, adapted to laboratory medicine, should be followed when developing recommendations involving the use of laboratory tests.
The following articles in journals at HighWire Press have cited this article:
![]() |
E. Nagy, J. Watine, P. S. Bunting, R. Onody, W. P. Oosterhuis, D. Rogic, S. Sandberg, K. Boda, and A. R. Horvath Do Guidelines for the Diagnosis and Monitoring of Diabetes Mellitus Fulfill the Criteria of Evidence-Based Guideline Development? Clin. Chem., November 1, 2008; 54(11): 1872 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Diamandis, B. R. Hoffman, and C. M. Sturgeon National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers Clin. Chem., November 1, 2008; 54(11): 1935 - 1939. [Full Text] [PDF] |
||||
![]() |
J. L. Spivak and R. T. Silver The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal Blood, July 15, 2008; 112(2): 231 - 239. [Full Text] [PDF] |
||||
![]() |
J. S. Madsen, M. Nybo, E. Magid, J. Hilden, N. Hornung, T. B. Larsen, L. Jorgensen, and P. E. Jorgensen More Studies on Outcomes Using Biochemical Diagnostic Tests Are Needed: Findings from the Danish Society of Clinical Biochemistry Clin. Chem., July 1, 2008; 54(7): 1254 - 1256. [Full Text] [PDF] |
||||
![]() |
J. S. Burgers Guideline Quality and Guideline Content: Are They Related? Clin. Chem., January 1, 2006; 52(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
J. Watine, B. Friedberg, E. Nagy, R. Onody, W. Oosterhuis, P. S. Bunting, J.-C. Charet, and A. R. Horvath Conflict between Guideline Methodologic Quality and Recommendation Validity: A Potential Problem for Practitioners Clin. Chem., January 1, 2006; 52(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |